Dr. Narayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd NE
Clinic Building B, Suite 1400
Atlanta, GA 30322Phone+1 404-778-4898Fax+1 404-778-4006- Is this information wrong?
Summary
- Dr. Vikram Narayan specializes in the surgical treatment of urologic cancers.
Dr. Narayan received his MD degree from the University of Florida College of Medicine in 2013. His general surgery internship and urology residency were done at the University of Minnesota, after which he completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer in 2020. During his fellowship, Dr. Narayan completed a year of basic science research investigating novel therapeutics for urothelial cancers including intravesical gene therapy, immune-based treatment options, and the role of the urinary microbiome in bladder cancer treatment.
Dr. Narayan's current research interests concentrate on understanding the mechanisms that underlie bladder cancer treatment responses in order to improve patients' therapeutic options. He has led projects studying quality outcomes for patients being treated for urothelial cancer. Dr. Narayan additionally has an interest in methodologic research, and has published several peer-reviewed articles about the performance of clinical urologic research and the transparent reporting of randomized trials and systematic reviews.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2018 - 2020
University of MinnesotaResidency, Urology, 2014 - 2018- University of MinnesotaResidency, Surgery, 2013 - 2014
University of Florida College of MedicineClass of 2013
Certifications & Licensure
GA State Medical License 2020 - 2026
TX State Medical License 2017 - 2025- American Board of Urology Urology
Publications & Presentations
PubMed
- Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.Nicaise, E., Schmeusser, B., Ali, A., Midenberg, E., Palacios, A., Hartsoe, B., Kearns, E., Ambadi, S., Patil, D., Joshi, S., Narayan, V., Psutka, S., Nazha, B., Brown...> ;Clinical Genitourinary Cancer. 2024 Feb 16
- Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.Lee, B., Smith, A., Lotan, Y., Agarwal, P., Black, P., Dickstein, R., Kamat, A., Narayan, V., Porten, S., Psutka, S., Svatek, R., Williams, S., Woldu, S.> ;Urologic Oncology. 2024 Feb 1
- Mechanism of action of nadofaragene firadenovec-vncg.Jørn S Jakobsen, Vikram M Narayan, Joshua J Meeks, Neal D Shore, Grannum R Sant, Badrinath R Konety> ;Frontiers in Oncology. 2024 Jan 1
- Join now to see all
Books/Book Chapters
Press Mentions
New Data Analyses from Phase 3 Study of Investigational Gene Therapy Nadofaragene Firadenovec Presented at Society of Urologic Oncology Annual Meeting Adds More Evidence to Data Published in Lancet OncologyDecember 2nd, 2020
MDACC 2018: Molecular Characterization of Upper Tract Urothelial CarcinomaNovember 11th, 2018- MDACC 2018: Molecular Characterization of Urothelial CarcinomaNovember 11th, 2018
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Emory University HospitalAtlanta, Georgia
Grady Health SystemAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
